Richard Messmann
Chief Medical Officer Convergent Therapeutics
Seminars
Tuesday 29th July 2025
Revealing the Lutathera & Pluvicto Stories from Bench to Bedside to Illustrate Prime Radiopharmaceutical Drug Development
8:30 am
- Exploring chemical structures, medicinal chemistry and delivery mechanisms
- Understanding key steps for successful translation and early clinical design
- Assembling the clinical workforce for the path to commercialization
Thursday 31st July 2025
Panel Discussion: Identifying Delays in Clinical Research to Streamline Development
11:30 am
• Industry-clinic collaborations
• Forward planning to avoid delays
• Accelerating development among nuclear medicine teams
Wednesday 30th July 2025
Panel Discussion: Exploring How Real-World Evidence Can Impact Design of Future RLT Trials
10:00 am
• Using real-world clinical outcomes to provide insights into patient populations, treatment efficacy and long-term safety
• Enhancing trial design through optimal patient selection, dosing strategies and endpoints
• Guiding potential personalized treatment strategies
Tuesday 29th July 2025
Panel Discussion: Commentary on Past & Future Developmental Pathways & Radiopharmaceutical Strategies
9:30 am
- Delving into the radiopharma landscape and technical development pathways
- Sharing experiences
